Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 10 of 34 for:    Lanreotide | Neuroendocrine Tumors

Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice. (PanNET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03947762
Recruitment Status : Recruiting
First Posted : May 13, 2019
Last Update Posted : July 25, 2019
Sponsor:
Information provided by (Responsible Party):
Ipsen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : January 31, 2023
  Estimated Study Completion Date : January 31, 2023